论文信息 - Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat - 字舞流文

Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat

Dhanunjaya R. Lakkireddy | Paul J. Wang | M. Chung | P. Noseworthy | E. Kaufman | A. Russo | L. Eckhardt | J. Joglar | R. Lampert | B. Olshansky | E. Wan | R. Gopinathannair | D. Lakkireddy | K. Sandau | Janet K. Han | K. Patton | M. Turagam | Alejandra Gutierrez | Jim W. Cheung | T. Gluckman | Joseph E. Marine | Miguel Leal | Bharath Rajagopalan | Parin Patel | Juan C. Sotomonte | Parin J. Patel | Parin J Patel

[1] P. Noseworthy,et al. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) , 2020, Mayo Clinic Proceedings.

[2] C. Eastin,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[3] Giuseppe Biondi-Zoccai,et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[4] Dylan H. Morris,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[5] Fenglian Ma,et al. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin , 2020, European heart journal.

[6] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[7] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[8] S. Yao,et al. Anesthetic Management of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection During Emergency Procedures. , 2020, Journal of cardiothoracic and vascular anesthesia.

[9] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[10] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[11] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[12] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[13] N. White,et al. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review , 2018, BMC Medicine.

[14] Renato Pietro Ricci,et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.

[15] Martin Traebert,et al. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. , 2004, European journal of pharmacology.

[16] Á. Cervera,et al. Cardiac toxicity secondary to long term treatment with chloroquine , 2001, Annals of the rheumatic diseases.

[17] D. Brodie,et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic , 2020 .

[18] P. Adeleine,et al. The hazards of chloroquine self prescription in west Africa. , 1995, Journal of toxicology. Clinical toxicology.